116 related articles for article (PubMed ID: 27731829)
1. Quantitative structure activity relationship (QSAR) studies on nitazoxanide-based analogues against Clostridium difficile In vitro.
Zhang H; Liu X; Yang Y; Li J
Pak J Pharm Sci; 2016 Sep; 29(5):1681-1689. PubMed ID: 27731829
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial and Solubility Optimization of Thiomuracin A.
LaMarche MJ; Leeds JA; Brewer J; Dean K; Ding J; Dzink-Fox J; Gamber G; Jain A; Kerrigan R; Krastel P; Lee K; Lombardo F; McKenney D; Neckermann G; Osborne C; Palestrant D; Patane MA; Rann EM; Robinson Z; Schmitt E; Stams T; Tiamfook S; Yu D; Whitehead L
J Med Chem; 2016 Jul; 59(14):6920-8. PubMed ID: 27355833
[TBL] [Abstract][Full Text] [Related]
3. Nitazoxanide is active against Clostridium difficile strains with reduced susceptibility to metronidazole.
Freeman J; Baines SD; Todhunter SL; Huscroft GS; Wilcox MH
J Antimicrob Chemother; 2011 Jun; 66(6):1407-8. PubMed ID: 21393199
[No Abstract] [Full Text] [Related]
4. Discovery of LFF571: an investigational agent for Clostridium difficile infection.
LaMarche MJ; Leeds JA; Amaral A; Brewer JT; Bushell SM; Deng G; Dewhurst JM; Ding J; Dzink-Fox J; Gamber G; Jain A; Lee K; Lee L; Lister T; McKenney D; Mullin S; Osborne C; Palestrant D; Patane MA; Rann EM; Sachdeva M; Shao J; Tiamfook S; Trzasko A; Whitehead L; Yifru A; Yu D; Yan W; Zhu Q
J Med Chem; 2012 Mar; 55(5):2376-87. PubMed ID: 22315981
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and QSAR modeling of novel benzimidazolo thiazolidinones, thiazinones and 5-arylidene-2-imino thiazolidinones as antibacterial agents.
Ghate M; Devi P; Parikh J; Vyas VK
Med Chem; 2013 May; 9(3):474-85. PubMed ID: 22920153
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antibacterial activity against Clostridium difficile of novel demethylvancomycin derivatives.
Zhang SJ; Yang Q; Xu L; Chang J; Sun X
Bioorg Med Chem Lett; 2012 Aug; 22(15):4942-5. PubMed ID: 22765891
[TBL] [Abstract][Full Text] [Related]
7. Purine analogs targeting the guanine riboswitch as potential antibiotics against Clostridioides difficile.
Yan LH; Le Roux A; Boyapelly K; Lamontagne AM; Archambault MA; Picard-Jean F; Lalonde-Seguin D; St-Pierre E; Najmanovich RJ; Fortier LC; Lafontaine D; Marsault É
Eur J Med Chem; 2018 Jan; 143():755-768. PubMed ID: 29220796
[TBL] [Abstract][Full Text] [Related]
8. Targeting methionyl tRNA synthetase: design, synthesis and antibacterial activity against Clostridium difficile of novel 3-biaryl-N-benzylpropan-1-amine derivatives.
Eissa AG; Blaxland JA; Williams RO; Metwally KA; El-Adl SM; Lashine el-SM; Baillie LW; Simons C
J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1694-7. PubMed ID: 26899668
[TBL] [Abstract][Full Text] [Related]
9. Quantitative structure-activity relationship (QSAR) studies of quinolone antibacterials against M. fortuitum and M. smegmatis using theoretical molecular descriptors.
Bagchi MC; Mills D; Basak SC
J Mol Model; 2007 Jan; 13(1):111-20. PubMed ID: 16932890
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, antibacterial, and QSAR studies of myristic acid derivatives.
Narasimhan B; Mourya V; Dhake A
Bioorg Med Chem Lett; 2006 Jun; 16(11):3023-9. PubMed ID: 16554156
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional QSAR analysis and design of new 1,2,4-oxadiazole antibacterials.
Leemans E; Mahasenan KV; Kumarasiri M; Spink E; Ding D; O'Daniel PI; Boudreau MA; Lastochkin E; Testero SA; Yamaguchi T; Lee M; Hesek D; Fisher JF; Chang M; Mobashery S
Bioorg Med Chem Lett; 2016 Feb; 26(3):1011-1015. PubMed ID: 26733473
[TBL] [Abstract][Full Text] [Related]
12. Thiosemicarbazones active against Clostridium difficile.
Costello C; Karpanen T; Lambert PA; Mistry P; Parker KJ; Rathbone DL; Ren J; Wheeldon L; Worthington T
Bioorg Med Chem Lett; 2008 Mar; 18(5):1708-11. PubMed ID: 18243694
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and 3D-QSAR studies of new diphenylamine containing 1,2,4-triazoles as potential antitubercular agents.
Mohan Krishna K; Inturi B; Pujar GV; Purohit MN; Vijaykumar GS
Eur J Med Chem; 2014 Sep; 84():516-29. PubMed ID: 25055342
[TBL] [Abstract][Full Text] [Related]
14. Role of Topological, Electronic, Geometrical, Constitutional and Quantum Chemical Based Descriptors in QSAR: mPGES-1 as a Case Study.
Gupta A; Kumar V; Aparoy P
Curr Top Med Chem; 2018; 18(13):1075-1090. PubMed ID: 30027847
[TBL] [Abstract][Full Text] [Related]
15. Exploring QSAR and QAAR for inhibitors of cytochrome P450 2A6 and 2A5 enzymes using GFA and G/PLS techniques.
Roy K; Roy PP
Eur J Med Chem; 2009 May; 44(5):1941-51. PubMed ID: 19110342
[TBL] [Abstract][Full Text] [Related]
16. Ligand-based prediction of active conformation by 3D-QSAR flexibility descriptors and their application in 3+3D-QSAR models.
Martinek TA; Otvös F; Dervarics M; Tóth G; Fülöp F
J Med Chem; 2005 May; 48(9):3239-50. PubMed ID: 15857130
[TBL] [Abstract][Full Text] [Related]
17. Exploring 3D-QSAR of thiazole and thiadiazole derivatives as potent and selective human adenosine A3 receptor antagonists+.
Bhattacharya P; Leonard JT; Roy K
J Mol Model; 2005 Nov; 11(6):516-24. PubMed ID: 15928917
[TBL] [Abstract][Full Text] [Related]
18. CoMFA QSAR models of camptothecin analogues based on the distinctive SAR features of combined ABC, CD and E ring substitutions.
Virupaksha B; Alpana G
Comput Biol Med; 2012 Sep; 42(9):890-7. PubMed ID: 22840194
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic optimization and chemical structure stabilization of thiomuracin A.
LaMarche MJ; Leeds JA; Dzink-Fox J; Gangl E; Krastel P; Neckermann G; Palestrant D; Patane MA; Rann EM; Tiamfook S; Yu D
J Med Chem; 2012 Aug; 55(15):6934-41. PubMed ID: 22812377
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and antibacterial activity of fluoroquinolones containing bulky arenesulfonyl fragment: 2D-QSAR and docking study.
Abdel-Aziz AA; Asiri YA; Al-Agamy MH
Eur J Med Chem; 2011 Nov; 46(11):5487-97. PubMed ID: 21982337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
